000 01267 a2200313 4500
005 20250517074033.0
264 0 _c20170711
008 201707s 0 0 eng d
022 _a1618-7601
024 7 _a10.1007/s10198-015-0758-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBanerjee, Tannista
245 0 0 _aWhy trash don't pass? pharmaceutical licensing and safety performance of drugs.
_h[electronic resource]
260 _bThe European journal of health economics : HEPAC : health economics in prevention and care
_cJan 2017
300 _a59-71 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDrug Approval
650 0 4 _aDrug Discovery
650 0 4 _aDrug Industry
_xlegislation & jurisprudence
650 0 4 _aHumans
650 0 4 _aLicensure
_xlegislation & jurisprudence
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aSafety-Based Drug Withdrawals
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aNayak, Arnab
773 0 _tThe European journal of health economics : HEPAC : health economics in prevention and care
_gvol. 18
_gno. 1
_gp. 59-71
856 4 0 _uhttps://doi.org/10.1007/s10198-015-0758-x
_zAvailable from publisher's website
999 _c25643261
_d25643261